
New research suggests immunosuppressants do not increase the risk of COVID-19.

New research suggests immunosuppressants do not increase the risk of COVID-19.

Annual awards program recognizes pharmacists, technicians, students and industry advocates who are defining the future of pharmacy.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

When examining the percentage of posts that made the vaccine seem more dangerous, less dangerous, or neither, Luisi found nearly 40% of Facebook posts about the HPV vaccine amplified a perceived risk.

In patients with severe cardiac failure, the extreme emaciation of the body is a potential result and has been termed cardiac cachexia.

A significantly greater proportion of patients with Crohn disease achieved both primary endpoints with overall safety results generally consistent with the known safety profile of risankizumab.

Darolutamide led to a 31% reduction in the risk of death, extending survival for patients with non-metastatic prostate cancer.

The online guide places a special emphasis on security, storage, and handling.

In the past week, Moderna and AstraZeneca have collectively announced multiple authorizations for use of their respective vaccines.

Despite the concerns that may come along with mutations of the SARS-CoV-2 virus, experts say the new strains do not call for any new prevention strategies.

In a recent study at the National Institutes of Health, researchers consistently observed signs of damage on the brain scans of patients who died after contracting COVID-19.

Pralatrexate, a lymphoma drug, outperformed remdesivir in treating COVID-19 in a lab experiment.

The first article in this 3-part series covered a general overview of the survey and its respondents. In this article, we will explore the questions and answers around compensation.

According to the study authors, this could lead to finding the exact molecular trigger and gives hope for developing a targeted PsA treatment in the future.













In the 16th century, it was quite easy to obtain poison, as apothecaries were in the business of making customers happy and the opportunity to poison people was one such source of joy.

FDA approves request submitted by Moleculin Biotech, Inc. for rare disease designations to be granted their drug candidate that appears to directly elicit tumor cell death and prompt the immune system to eliminate tumors.

Pharmacists must juggle the delicate balance of integrating clinical services into traditional dispensing environments, while being forced into performance metrics set forth by corporate entities.

Socioeconomic and racial health disparities contribute to worse cancer and COVID-19 outcomes.